Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitorsJOURNAL OF CONTROLLED RELEASEIF11.52016-07-0133PREAI
The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemiaJOURNAL OF CONTROLLED RELEASEIF11.52016-02-0136PREAI
Polymer inhibitors of ABC transporter overcoming multidrug resistance: Synthesis, characterization and in vitro evaluationJOURNAL OF CONTROLLED RELEASEIF11.52015-09-014PRE
Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumoursJOURNAL OF CONTROLLED RELEASEIF11.52015-07-0123OAAI
Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl) methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage (vol 174, pg 81, 2014)JOURNAL OF CONTROLLED RELEASEIF11.52014-05-010OAAI
Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl) methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkageJOURNAL OF CONTROLLED RELEASEIF11.52014-01-0195PRE
Dual fluorescent HPMA copolymers for passive tumor targeting with pH- sensitive drug release II: Impact of release rate on biodistributionJOURNAL OF CONTROLLED RELEASEIF11.52013-12-0149PRE
Micelles of zinc protoporphyrin conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer for imaging and light-induced antitumor effects in vivoJOURNAL OF CONTROLLED RELEASEIF11.52013-02-0160PRE
Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyesterJOURNAL OF CONTROLLED RELEASEIF11.52013-01-0168PRE
HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activityJOURNAL OF CONTROLLED RELEASEIF11.52012-12-01129PRE
Noninvasive Optical Imaging of Nanomedicine Biodistribution纳米医学生物分布的无创光学成像ACS NANOIF162012-10-24104OA
Polymer coatings for delivery of nucleic acid therapeuticsJOURNAL OF CONTROLLED RELEASEIF11.52012-07-0153PREAI
Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacyJOURNAL OF CONTROLLED RELEASEIF11.52011-09-01173PREAI
Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectinsJOURNAL OF CONTROLLED RELEASEIF11.52011-03-0127OAAI
HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activityJOURNAL OF CONTROLLED RELEASEIF11.52009-11-0151PRE
Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood componentsJOURNAL OF CONTROLLED RELEASEIF11.52009-04-0161PRE
Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targetingJOURNAL OF CONTROLLED RELEASEIF11.52008-12-0196PRE
Biodegradable high-molecular-weight multiblock polymers based on poly(ethylene glycol) for drug deliveryJOURNAL OF CONTROLLED RELEASEIF11.52008-12-011PRE
Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapyJOURNAL OF CONTROLLED RELEASEIF11.52007-09-0158PRE